204 related articles for article (PubMed ID: 34956399)
1. Protumor Effects of Histone H3-H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and
Wu L; Jie B
Comput Math Methods Med; 2021; 2021():5005459. PubMed ID: 34956399
[TBL] [Abstract][Full Text] [Related]
2. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma.
Mao CG; Jiang SS; Wang XY; Tao SL; Jiang B; Mao CY; Yang YL; Hu ZY; Long T; Jin H; Tan QY; Huang Y; Deng B
Int J Biol Sci; 2021; 17(10):2461-2475. PubMed ID: 34326687
[No Abstract] [Full Text] [Related]
3. Elevated expression of
Feng Z; Zhang J; Zheng Y; Wang Q; Min X; Tian T
Per Med; 2021 Mar; 18(2):115-127. PubMed ID: 33576264
[No Abstract] [Full Text] [Related]
4. Carcinogenic Role and Clinical Significance of Histone H3-H4 Chaperone Anti-silencing Function 1 B (ASF1B) in Lung Adenocarcinoma.
Song C; Song Y; Wan X; Zhao Z; Geng Q
J Cancer; 2024; 15(1):218-231. PubMed ID: 38164276
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
8. High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
Jiang S; Mao C; Jiang B; Tan Q; Deng B
Technol Cancer Res Treat; 2020; 19():1533033820983086. PubMed ID: 33334252
[TBL] [Abstract][Full Text] [Related]
9. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
10. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
[TBL] [Abstract][Full Text] [Related]
11. The lncRNA ALMS1-IT1 may promote malignant progression of lung adenocarcinoma via AVL9-mediated activation of the cyclin-dependent kinase pathway.
Luan T; Zhang TY; Lv ZH; Guan BX; Xu JY; Li J; Li MX; Hu SL
FEBS Open Bio; 2021 May; 11(5):1504-1515. PubMed ID: 33683834
[TBL] [Abstract][Full Text] [Related]
12. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
13. miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.
Hu C; Wu J; Wang L; Liu X; Da B; Liu Y; Huang L; Chen Q; Tong Y; Jiang Z
Pathol Res Pract; 2021 Jul; 223():153459. PubMed ID: 33971546
[TBL] [Abstract][Full Text] [Related]
14.
Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
[TBL] [Abstract][Full Text] [Related]
15. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
[TBL] [Abstract][Full Text] [Related]
16. miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.
Li J; He X; Wu X; Liu X; Huang Y; Gong Y
Comput Math Methods Med; 2020; 2020():2953598. PubMed ID: 33204298
[TBL] [Abstract][Full Text] [Related]
17. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
[TBL] [Abstract][Full Text] [Related]
18. ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway.
Wang W; Xiao L; Pan D; Hu L
Neoplasma; 2022 Mar; 69(2):361-369. PubMed ID: 35103478
[TBL] [Abstract][Full Text] [Related]
19. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
Ren K; Yu Y; Wang X; Liu H; Zhao J
Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383
[TBL] [Abstract][Full Text] [Related]
20. m
Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y
J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
